Propanc Biopharma Receives Orphan Drug Designation from...

2017-06-26T17:20:38-07:00

Propanc Biopharma Receives Orphan Drug Designation from FDA for Treatment of Pancreatic Cancer MELBOURNE, AUSTRALIA--(Marketwired - June 27, 2017) - Propanc Biopharma Inc. (PPCB), a clinical stage biopharmaceutical company focusing on ...